⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2813665 | 0.69 | — | — | |
| SCHEMBL8015936 | 0.64 | — | — | |
| SCHEMBL28452785 | 0.64 | — | — | |
| SCHEMBL14139575 | 0.57 | — | — | |
| SCHEMBL2813619 | 0.57 | — | — | |
| SCHEMBL1611850 | 0.57 | — | — | |
| SCHEMBL6295270 | 0.56 | — | — | |
| SCHEMBL27275935 | 0.55 | — | — | |
| SCHEMBL2813662 | 0.54 | — | — | |
| SCHEMBL13905033 | 0.51 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2274281-B1 | HCV PROTEASE INHIBITORS | TAIGEN BIOTECHNOLOGY CO LTD (TW) | 2015-05-27 | — | — | EP | disclosed |